Brief: Sandoz Launches Rivaroxaban In Germany, Expanding Access To High-Quality Antithrombotic Treatment Options
28/08/2025 06:07
Aug 28 (Reuters) - SANDOZ GROUP AG SDZ.S: LAUNCHES RIVAROXABAN IN GERMANY RIVAROXABAN OFFERS AFFORDABLE ALTERNATIVE TO XARELTO Source text: ID:nEQ1ZWjTWa Further company coverage: SDZ.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sandoz AG
See all newsPfizer dismissed from US states' drug price-fixing lawsuit (updated)
Pfizer dismissed from US states' drug price-fixing lawsuit
Factbox: Major investment pledges at Choose France summit
Press Digest: Financial Times - June 1
Media: Sandoz warns cheap Chinese imports threaten Europe’s antibiotic supply- FT